| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dendritic Cells | 21 | 2025 | 534 | 4.080 |
Why?
|
| Lupus Erythematosus, Systemic | 12 | 2026 | 186 | 3.950 |
Why?
|
| Interferon Type I | 9 | 2026 | 198 | 2.320 |
Why?
|
| Autoantibodies | 9 | 2026 | 187 | 1.500 |
Why?
|
| Lupus Nephritis | 3 | 2024 | 38 | 1.450 |
Why?
|
| Autoimmunity | 7 | 2026 | 251 | 1.440 |
Why?
|
| Biofilms | 6 | 2024 | 86 | 1.250 |
Why?
|
| Interferon-alpha | 3 | 2024 | 101 | 1.100 |
Why?
|
| DNA | 3 | 2024 | 853 | 0.980 |
Why?
|
| STAT2 Transcription Factor | 7 | 2020 | 9 | 0.930 |
Why?
|
| Signal Transduction | 10 | 2026 | 3171 | 0.900 |
Why?
|
| Myeloid Cells | 3 | 2026 | 98 | 0.820 |
Why?
|
| Macrophage Activation Syndrome | 1 | 2024 | 5 | 0.810 |
Why?
|
| Animals | 39 | 2026 | 21494 | 0.800 |
Why?
|
| ErbB Receptors | 1 | 2024 | 129 | 0.790 |
Why?
|
| Mice | 33 | 2026 | 11183 | 0.780 |
Why?
|
| Salmonella typhimurium | 5 | 2026 | 87 | 0.780 |
Why?
|
| Vibrio cholerae | 1 | 2023 | 18 | 0.780 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2024 | 198 | 0.760 |
Why?
|
| Toll-Like Receptor 9 | 4 | 2019 | 207 | 0.740 |
Why?
|
| Salmonella Infections | 5 | 2026 | 43 | 0.690 |
Why?
|
| Receptor, Interferon alpha-beta | 3 | 2026 | 54 | 0.680 |
Why?
|
| Mice, Inbred C57BL | 19 | 2026 | 3507 | 0.660 |
Why?
|
| Cytokines | 8 | 2024 | 967 | 0.660 |
Why?
|
| Interleukin-4 | 2 | 2014 | 147 | 0.650 |
Why?
|
| Immunity, Innate | 4 | 2024 | 829 | 0.630 |
Why?
|
| Autoantigens | 2 | 2019 | 140 | 0.620 |
Why?
|
| Interleukin-27 | 1 | 2019 | 7 | 0.590 |
Why?
|
| Toll-Like Receptors | 3 | 2019 | 434 | 0.590 |
Why?
|
| Epoxy Compounds | 1 | 2019 | 11 | 0.590 |
Why?
|
| Furans | 1 | 2019 | 28 | 0.590 |
Why?
|
| Pyruvates | 1 | 2019 | 3 | 0.580 |
Why?
|
| Immunomodulation | 1 | 2019 | 30 | 0.570 |
Why?
|
| Interferon-beta | 3 | 2014 | 79 | 0.560 |
Why?
|
| Interleukin-10 | 1 | 2019 | 163 | 0.550 |
Why?
|
| Bacterial Infections | 1 | 2019 | 151 | 0.540 |
Why?
|
| Fatty Acids | 1 | 2019 | 200 | 0.540 |
Why?
|
| Macrophage-1 Antigen | 2 | 2008 | 29 | 0.540 |
Why?
|
| Up-Regulation | 4 | 2018 | 377 | 0.530 |
Why?
|
| Cross-Priming | 2 | 2020 | 15 | 0.510 |
Why?
|
| Estradiol | 2 | 2018 | 260 | 0.510 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2017 | 36 | 0.510 |
Why?
|
| Cells, Cultured | 10 | 2026 | 2192 | 0.510 |
Why?
|
| Spleen | 4 | 2026 | 476 | 0.490 |
Why?
|
| Energy Metabolism | 1 | 2019 | 396 | 0.460 |
Why?
|
| Inflammation | 5 | 2026 | 1196 | 0.460 |
Why?
|
| Mice, Knockout | 10 | 2026 | 2170 | 0.450 |
Why?
|
| Amyloid | 4 | 2022 | 74 | 0.420 |
Why?
|
| Lentivirus Infections | 1 | 2014 | 1 | 0.410 |
Why?
|
| Exodeoxyribonucleases | 1 | 2014 | 29 | 0.410 |
Why?
|
| DNA, Bacterial | 3 | 2024 | 262 | 0.400 |
Why?
|
| Disease Models, Animal | 6 | 2024 | 2327 | 0.400 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2014 | 104 | 0.380 |
Why?
|
| Lymphocyte Activation | 4 | 2019 | 755 | 0.380 |
Why?
|
| Phosphoproteins | 1 | 2014 | 224 | 0.370 |
Why?
|
| Membrane Glycoproteins | 2 | 2014 | 667 | 0.370 |
Why?
|
| NF-kappa B | 1 | 2014 | 436 | 0.350 |
Why?
|
| Humans | 28 | 2026 | 65872 | 0.350 |
Why?
|
| Interferons | 1 | 2012 | 74 | 0.350 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2016 | 679 | 0.340 |
Why?
|
| Opsonin Proteins | 2 | 2008 | 32 | 0.340 |
Why?
|
| Cellular Senescence | 1 | 2012 | 121 | 0.340 |
Why?
|
| Mice, Inbred NZB | 3 | 2024 | 21 | 0.330 |
Why?
|
| Transcriptome | 3 | 2026 | 409 | 0.320 |
Why?
|
| Lipopolysaccharides | 4 | 2026 | 625 | 0.310 |
Why?
|
| STAT1 Transcription Factor | 4 | 2014 | 35 | 0.300 |
Why?
|
| Bacterial Proteins | 4 | 2022 | 741 | 0.290 |
Why?
|
| Female | 18 | 2026 | 34459 | 0.290 |
Why?
|
| Ligands | 3 | 2019 | 414 | 0.290 |
Why?
|
| Microbiota | 2 | 2023 | 172 | 0.280 |
Why?
|
| Kidney | 3 | 2024 | 460 | 0.280 |
Why?
|
| Complement C3b | 1 | 2008 | 18 | 0.280 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2019 | 74 | 0.280 |
Why?
|
| Imidazoles | 3 | 2019 | 82 | 0.270 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 739 | 0.270 |
Why?
|
| Apoptosis | 4 | 2026 | 1099 | 0.270 |
Why?
|
| Gene Expression Regulation | 3 | 2021 | 1635 | 0.270 |
Why?
|
| Th2 Cells | 1 | 2007 | 94 | 0.260 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2023 | 274 | 0.260 |
Why?
|
| Cell Survival | 2 | 2019 | 588 | 0.250 |
Why?
|
| Salmonella Infections, Animal | 1 | 2026 | 10 | 0.240 |
Why?
|
| Fibrosis | 2 | 2024 | 172 | 0.240 |
Why?
|
| Fibroblasts | 2 | 2026 | 423 | 0.240 |
Why?
|
| Paracrine Communication | 2 | 2021 | 17 | 0.240 |
Why?
|
| Lupus Vulgaris | 1 | 2006 | 3 | 0.240 |
Why?
|
| Photosensitivity Disorders | 1 | 2026 | 6 | 0.240 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2026 | 65 | 0.230 |
Why?
|
| Keratinocytes | 1 | 2026 | 76 | 0.230 |
Why?
|
| Antigen Presentation | 4 | 2025 | 239 | 0.230 |
Why?
|
| Cancer Vaccines | 1 | 2025 | 51 | 0.220 |
Why?
|
| Autoimmune Diseases | 3 | 2022 | 240 | 0.220 |
Why?
|
| Antibodies, Antinuclear | 2 | 2020 | 42 | 0.210 |
Why?
|
| Antibodies, Monoclonal | 2 | 2020 | 875 | 0.210 |
Why?
|
| Quinazolines | 1 | 2024 | 21 | 0.210 |
Why?
|
| Macrophages | 5 | 2025 | 1042 | 0.210 |
Why?
|
| Phenotype | 2 | 2021 | 1236 | 0.210 |
Why?
|
| CD40 Antigens | 2 | 2019 | 59 | 0.210 |
Why?
|
| Adjuvants, Immunologic | 1 | 2025 | 238 | 0.210 |
Why?
|
| Interferon Regulatory Factor-7 | 3 | 2018 | 33 | 0.200 |
Why?
|
| Oligodeoxyribonucleotides | 3 | 2019 | 242 | 0.200 |
Why?
|
| Escherichia coli | 2 | 2020 | 719 | 0.190 |
Why?
|
| T-Lymphocytes | 4 | 2021 | 1013 | 0.190 |
Why?
|
| Bone Marrow Cells | 2 | 2018 | 237 | 0.190 |
Why?
|
| Neutrophils | 1 | 2026 | 396 | 0.190 |
Why?
|
| Vaccination | 1 | 2025 | 388 | 0.180 |
Why?
|
| Arthritis | 1 | 2023 | 53 | 0.180 |
Why?
|
| Mammals | 1 | 2024 | 223 | 0.180 |
Why?
|
| Interleukin-6 | 3 | 2018 | 324 | 0.180 |
Why?
|
| Liver Diseases | 1 | 2023 | 157 | 0.180 |
Why?
|
| Extracellular Matrix | 1 | 2023 | 148 | 0.180 |
Why?
|
| Chemokine CXCL10 | 2 | 2019 | 56 | 0.180 |
Why?
|
| Lung Diseases | 1 | 2023 | 183 | 0.180 |
Why?
|
| Mice, Transgenic | 3 | 2018 | 1292 | 0.180 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2023 | 263 | 0.170 |
Why?
|
| Heart Diseases | 1 | 2023 | 223 | 0.170 |
Why?
|
| Autocrine Communication | 2 | 2014 | 30 | 0.170 |
Why?
|
| Stem Cell Transplantation | 1 | 2021 | 79 | 0.170 |
Why?
|
| Macrophage Activation | 1 | 2021 | 115 | 0.170 |
Why?
|
| Multipotent Stem Cells | 1 | 2021 | 15 | 0.160 |
Why?
|
| Bacteriuria | 1 | 2020 | 16 | 0.160 |
Why?
|
| Transplantation Tolerance | 1 | 2021 | 69 | 0.160 |
Why?
|
| Antibody Formation | 1 | 2020 | 111 | 0.160 |
Why?
|
| Bacteria | 1 | 2024 | 337 | 0.160 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 180 | 0.160 |
Why?
|
| Dysbiosis | 1 | 2021 | 75 | 0.160 |
Why?
|
| Wound Healing | 1 | 2021 | 193 | 0.160 |
Why?
|
| Graft vs Host Disease | 1 | 2021 | 113 | 0.150 |
Why?
|
| Inflammasomes | 1 | 2023 | 352 | 0.150 |
Why?
|
| Molecular Mimicry | 1 | 2019 | 31 | 0.150 |
Why?
|
| Stem Cells | 1 | 2021 | 278 | 0.150 |
Why?
|
| Nanoparticles | 1 | 2025 | 552 | 0.150 |
Why?
|
| Myocardium | 1 | 2021 | 301 | 0.150 |
Why?
|
| Genetic Variation | 1 | 2021 | 396 | 0.140 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2021 | 304 | 0.140 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 80 | 0.140 |
Why?
|
| Kallikrein-Kinin System | 1 | 2018 | 1 | 0.140 |
Why?
|
| Bradykinin | 1 | 2018 | 8 | 0.140 |
Why?
|
| Cell Death | 1 | 2019 | 289 | 0.140 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 408 | 0.130 |
Why?
|
| Lymph Nodes | 1 | 2019 | 237 | 0.130 |
Why?
|
| Nitric Oxide | 1 | 2019 | 165 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 216 | 0.130 |
Why?
|
| Plants | 1 | 2017 | 50 | 0.130 |
Why?
|
| Transcriptional Activation | 2 | 2018 | 197 | 0.130 |
Why?
|
| Benzhydryl Compounds | 1 | 2017 | 61 | 0.120 |
Why?
|
| Estrogens | 1 | 2017 | 115 | 0.120 |
Why?
|
| Nucleotidyltransferases | 1 | 2017 | 66 | 0.120 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2017 | 219 | 0.120 |
Why?
|
| Phenols | 1 | 2017 | 77 | 0.120 |
Why?
|
| Male | 9 | 2026 | 31435 | 0.120 |
Why?
|
| Neoplasms | 2 | 2025 | 1378 | 0.120 |
Why?
|
| Cell Nucleus | 1 | 2019 | 634 | 0.120 |
Why?
|
| Mesangial Cells | 1 | 2015 | 2 | 0.110 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2015 | 15 | 0.110 |
Why?
|
| Phagocytosis | 2 | 2008 | 257 | 0.110 |
Why?
|
| Chemokine CCL2 | 1 | 2015 | 61 | 0.110 |
Why?
|
| Immunity | 1 | 2016 | 107 | 0.110 |
Why?
|
| Escherichia coli Infections | 1 | 2015 | 90 | 0.110 |
Why?
|
| Myocardial Infarction | 1 | 2021 | 922 | 0.110 |
Why?
|
| Germinal Center | 2 | 2026 | 40 | 0.100 |
Why?
|
| Tumor Burden | 1 | 2014 | 77 | 0.100 |
Why?
|
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2014 | 5 | 0.100 |
Why?
|
| Melanoma, Experimental | 1 | 2014 | 43 | 0.100 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2014 | 14 | 0.100 |
Why?
|
| Cell Differentiation | 2 | 2017 | 1391 | 0.100 |
Why?
|
| Ubiquitins | 1 | 2014 | 42 | 0.100 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2011 | 41 | 0.090 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 1226 | 0.080 |
Why?
|
| Endocytosis | 1 | 2011 | 152 | 0.080 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2025 | 351 | 0.080 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2009 | 31 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2017 | 605 | 0.070 |
Why?
|
| Glomerulonephritis | 1 | 2009 | 31 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 645 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2015 | 716 | 0.070 |
Why?
|
| Necrosis | 1 | 2009 | 147 | 0.070 |
Why?
|
| HIV-1 | 1 | 2014 | 710 | 0.070 |
Why?
|
| Parasitic Diseases, Animal | 1 | 2007 | 1 | 0.070 |
Why?
|
| Myxovirus Resistance Proteins | 1 | 2007 | 5 | 0.070 |
Why?
|
| Receptors, Interferon | 1 | 2007 | 20 | 0.070 |
Why?
|
| Interleukin-15 | 1 | 2007 | 25 | 0.070 |
Why?
|
| Histocompatibility Antigens | 1 | 2007 | 107 | 0.060 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 712 | 0.060 |
Why?
|
| Genetic Vectors | 1 | 2014 | 930 | 0.060 |
Why?
|
| Interleukin-12 | 2 | 2018 | 127 | 0.060 |
Why?
|
| GTP-Binding Proteins | 1 | 2007 | 93 | 0.060 |
Why?
|
| HIV Infections | 1 | 2014 | 961 | 0.060 |
Why?
|
| Immunophenotyping | 1 | 2007 | 194 | 0.060 |
Why?
|
| Virus Diseases | 1 | 2007 | 118 | 0.060 |
Why?
|
| Kinetics | 1 | 2008 | 760 | 0.060 |
Why?
|
| Genetic Therapy | 1 | 2014 | 851 | 0.060 |
Why?
|
| B7-2 Antigen | 1 | 2006 | 32 | 0.060 |
Why?
|
| Dermatomyositis | 1 | 2026 | 11 | 0.060 |
Why?
|
| B7-1 Antigen | 1 | 2006 | 74 | 0.060 |
Why?
|
| Mercuric Chloride | 1 | 2005 | 6 | 0.060 |
Why?
|
| Mice, Inbred Strains | 1 | 2006 | 185 | 0.060 |
Why?
|
| Disease Susceptibility | 1 | 2006 | 170 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 2 | 2021 | 869 | 0.060 |
Why?
|
| Ultraviolet Rays | 1 | 2026 | 153 | 0.050 |
Why?
|
| Mice, 129 Strain | 2 | 2015 | 41 | 0.050 |
Why?
|
| Time Factors | 1 | 2012 | 3780 | 0.050 |
Why?
|
| Cell Line | 1 | 2008 | 2032 | 0.050 |
Why?
|
| Bacteroidetes | 1 | 2023 | 6 | 0.050 |
Why?
|
| Amyloidogenic Proteins | 1 | 2023 | 14 | 0.050 |
Why?
|
| B-Lymphocytes | 2 | 2022 | 566 | 0.050 |
Why?
|
| Flow Cytometry | 2 | 2017 | 665 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2026 | 1150 | 0.050 |
Why?
|
| Immunity, Mucosal | 1 | 2023 | 53 | 0.050 |
Why?
|
| Skin | 1 | 2026 | 436 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2026 | 799 | 0.050 |
Why?
|
| Peptides | 1 | 2006 | 593 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2023 | 276 | 0.040 |
Why?
|
| Cortical Bone | 1 | 2021 | 1 | 0.040 |
Why?
|
| Swine, Miniature | 1 | 2021 | 9 | 0.040 |
Why?
|
| Videoconferencing | 1 | 2021 | 10 | 0.040 |
Why?
|
| Drug Repositioning | 1 | 2021 | 11 | 0.040 |
Why?
|
| Ubiquinone | 1 | 2021 | 22 | 0.040 |
Why?
|
| Congresses as Topic | 1 | 2021 | 78 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2021 | 95 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 1570 | 0.040 |
Why?
|
| Middle Aged | 3 | 2026 | 18518 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2005 | 793 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 140 | 0.040 |
Why?
|
| Swine | 1 | 2021 | 398 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 119 | 0.040 |
Why?
|
| Metformin | 1 | 2021 | 77 | 0.040 |
Why?
|
| Aging | 1 | 2006 | 784 | 0.040 |
Why?
|
| Catheter-Related Infections | 1 | 2020 | 42 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2005 | 930 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2023 | 719 | 0.040 |
Why?
|
| Epitopes | 1 | 2020 | 291 | 0.040 |
Why?
|
| Child | 2 | 2021 | 4656 | 0.030 |
Why?
|
| Tissue Kallikreins | 1 | 2018 | 2 | 0.030 |
Why?
|
| Captopril | 1 | 2018 | 8 | 0.030 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2017 | 18 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 1172 | 0.030 |
Why?
|
| Adolescent | 2 | 2021 | 6371 | 0.030 |
Why?
|
| Adult | 2 | 2026 | 17595 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 1573 | 0.030 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 2015 | 4 | 0.030 |
Why?
|
| Infant | 1 | 2021 | 1721 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 710 | 0.030 |
Why?
|
| Polymerization | 1 | 2015 | 36 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2021 | 2090 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2014 | 52 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 542 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 167 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 2653 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2014 | 145 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2005 | 503 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2014 | 327 | 0.020 |
Why?
|
| Ovalbumin | 1 | 2011 | 108 | 0.020 |
Why?
|
| Cell Separation | 1 | 2011 | 148 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2011 | 139 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 589 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 611 | 0.020 |
Why?
|
| Risk Factors | 1 | 2020 | 5477 | 0.020 |
Why?
|
| Young Adult | 1 | 2020 | 4887 | 0.020 |
Why?
|
| Survival Rate | 1 | 2009 | 849 | 0.020 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-1 | 1 | 2006 | 2 | 0.020 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2006 | 6 | 0.020 |
Why?
|
| Receptors, LDL | 1 | 2006 | 35 | 0.020 |
Why?
|
| Sex Factors | 1 | 2009 | 995 | 0.010 |
Why?
|
| Transmembrane Activator and CAML Interactor Protein | 1 | 2005 | 2 | 0.010 |
Why?
|
| Heat-Shock Proteins | 1 | 2006 | 71 | 0.010 |
Why?
|
| B-Cell Activating Factor | 1 | 2005 | 9 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 2005 | 84 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2005 | 64 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 2005 | 21 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2005 | 34 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 2005 | 81 | 0.010 |
Why?
|
| Receptors, IgG | 1 | 2005 | 41 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2005 | 115 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2006 | 344 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2006 | 211 | 0.010 |
Why?
|
| Vaccines | 1 | 2006 | 97 | 0.010 |
Why?
|
| Disease Progression | 1 | 2009 | 1231 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 15155 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2005 | 372 | 0.010 |
Why?
|
| Histones | 1 | 2005 | 497 | 0.010 |
Why?
|
| Chromatin | 1 | 2005 | 643 | 0.010 |
Why?
|